Evidence from a Multistate Cohort: Enrollment in Affordable Care Act Qualified Health Plans' Association with Viral Suppression.

Clicks: 411
ID: 65972
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #76 of 552 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 552 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Healthcare delivery changes associated with viral suppression (VS) could contribute to the United States' "Ending the HIV Epidemic" (EtHE) initiative. This study aims to determine whether Qualified Health Plans (QHPs) purchased by AIDS Drug Assistance Programs (ADAPs) are associated with VS for low-income people living with HIV (PLWH) across three states.A multistate cohort of ADAP clients who were eligible for ADAP-funded QHPs were studied (2014-2015). A log-binomial model was used to estimate the association of demographics and healthcare delivery factors with QHP enrollment prevalence and one-year risk of VS. A number needed to treat/enroll (NNT) for one additional person to achieve viral suppression was calculated.Of the cohort (n=7776), 52% enrolled in QHPs. QHP enrollment in 2015 was associated with QHP coverage in 2014 (adjusted prevalence ratio [aPR] 3.28; 95% confidence interval 3.06-3.53) and engagement in care in 2014 (aPR 1.16; 1.04-1.28).PLWH who were engaged in care (n=4597) and had QHPs had a higher VS rate than those who received medications from Direct ADAP (86.0% vs. 80.2%). QHPs' NNT for an additional person to achieve VS is 20 (14.1-34.5). Starting undetectable (adjusted risk ratio [aRR] 1.39; 1.28-1.52) and enrolling in QHPs in 2015 (aRR 1.06; 0.99-1.14) was associated with VS.Once enrolled in ADAP-funded QHPs, ADAP clients stay enrolled. Enrollment is associated with VS across states and demographic groups. ADAPs, especially in the South and in Medicaid non-expansion states, should consider investing in QHPs because increased enrollment could improve VS rates. This evidence-based intervention could be a part of EtHE.
Reference Key
mcmanus2019evidenceclinical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors McManus, Kathleen A;Christensen, Bianca;Nagraj, V Peter;Furl, Renae;Yerkes, Lauren;Swindells, Susan;Weissman, Sharon;Rhodes, Anne;Targonski, Paul;McQuade, Elizabeth Rogawski;Dillingham, Rebecca;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2019
DOI
ciz1123
URL
Keywords
hiv health insurance patient protection and affordable care act health care reform aids drug assistance program

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.